Apex Announces Closing of Over-Allotment Option

The additional issuance brings in funding at US$4.65 per ADS while diluting existing holders.

Rhea-AI Summary

Apex Critical Metals (APXC) has issued an additional 60,000 American Depositary Shares following full exercise of its underwriter's over-allotment option.

The additional shares were issued at the public offering price of US$4.65 per share in connection with the company's previously announced public offering. Maxim Group acted as sole book-running manager. The offering used an effective shelf registration statement, and no securities were offered or sold to Canadian purchasers.

Positive

• Minor pointFull exercise of the over-allotment option adds funding through 60,000 additional ADSs.

Negative

• Minor point60,000 additional ADSs at US$4.65 each dilute existing holders.

News Explained

Apex has issued the additional ADSs, increasing the share count; absent offsetting changes, this reduces existing holders’ percentage ownership.

Key Figures

Additional ADSs issued: 60,000 ADSs Public offering price: US$4.65 per ADS

Additional ADSs issued

60,000 ADSs

Full exercise of the underwriter's over-allotment option

Public offering price

US$4.65 per ADS

Price for the additional ADSs issued

Key Terms

american depositary shares, over-allotment option, shelf registration statement, form f-10

4 terms

american depositary shares financial

"60,000 American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

over-allotment option financial

"full exercise of the underwriter's over-allotment option"

An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.

shelf registration statement regulatory

"effective shelf registration statement on Form F-10"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form f-10 regulatory

"shelf registration statement on Form F-10"

Form F-10 is a standardized prospectus document filed with Canadian securities regulators when a Canadian company offers shares or other securities to the public. It lays out the company’s business, financial results, management, and risks—like a detailed product label that helps investors compare what they’re buying and understand potential downsides. For investors, the form matters because it provides the core information needed to evaluate the safety, value and terms of a public securities offering.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC / ACCESS Newswire / October 27, 2026 / Apex Critical Metals Corp. (NASDAQ:APXC)(CSE:APXC)(OTCQX:APXCF)(FWB:KL9)(Euronext Access Paris:MLAPX) ("Apex" or the "Company"), a mineral exploration company focused on advancing its strategic 100%-controlled Rift Rare Earth Project within the Elk Creek Carbonatite Complex in southeastern Nebraska, U.S.A., today announced that it has issued an additional 60,000 American Depositary Shares ("ADSs") at the public offering price of US$4.65 per share pursuant to the full exercise of the underwriter's over-allotment option in connection with the Company's previously announced public offering of ADSs (the "Offering").

Maxim Group LLC acted as sole book-running manager for the Offering.

The Offering was made pursuant to an effective shelf registration statement on Form F-10 (File No. 333-298319) previously filed with the U.S. Securities and Exchange Commission (the "SEC") and became effective on August 13, 2026. No securities were offered or sold to Canadian purchasers under the Offering. A final prospectus supplement and accompanying prospectus relating to the Offering and describing the terms thereof was filed with the SEC and forms a part of the effective registration statement and is available on the SEC's website at www.sec.gov and on SEDAR+ website at www.sedarplus.ca. Copies of the final prospectus supplement and accompanying prospectus may be obtained by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, or by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

On behalf of the Board of Directors

APEX CRITICAL METALS CORP.,
Sean Charland
Chief Executive Officer
Tel: 604.681.1568
Email: info@apexcriticalmetals.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Apex Critical Metals Corp.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many additional shares did Apex Critical Metals issue under its over-allotment option, and at what price?

Apex issued 60,000 additional American Depositary Shares at US$4.65 per share. The issuance followed full exercise of the underwriter's over-allotment option connected to its previously announced public offering.